AI Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

This review was jointly published by Prof. Long-Jiang Zhang (Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University) and Prof. Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

With the continuous progress of science and technology, artificial intelligence (AI) has become an important driving force for a new round of scientific and technological revolution and industrial change. It aims to mimic human consciousness and thought processes, continuously learn and improve, and show a response close to or even beyond a real person. At present, machine learning, deep learning, and other AI technologies have been tried to be applied to intelligent diagnostic and decision making, image interpretation, accurate classification, and prognostication of cardiovascular diseases, which has led to broad application prospects and innovation potential.

As a safe and reliable non-invasive technique of choice for clinical screening of coronary heart disease, coronary CT angiography (CCTA) has been recommended by guidelines of the European and American societies as the use of Class 1A evidence for coronary artery disease. In recent years, the attempts of AI to run through the whole process of CCTA have expanded the application scope of CCTA. AI has shown great potential and advantages in many aspects of CCTA, including image quality optimization, fully automated calculation, quantitative and qualitative evaluation, etc.

This review systematically introduces the common AI techniques in the field of cardiovascular computed tomography (CT), summarizes the current research and application progress of AI in cardiovascular CT, and provides its future perspectives. We believe that the digital and intelligent management model of cardiovascular disease is expected to improve the management level and efficiency of diseases and provide patients with more accurate, safe, and appropriate diagnosis and treatment methods.

Peng-Peng Xu, Tong-Yuan Liu, Fan Zhou, Qian Chen, Jacob Rowe, Christian Tesche, Long-Jiang Zhang.
Artificial intelligence in coronary computed tomography angiography.
Medicine Plus, 2024. doi: 10.1016/j.medp.2023.100001

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...